404 related articles for article (PubMed ID: 32048306)
21. SP1-induced upregulation of long noncoding RNA LINC00313 contributes to papillary thyroid cancer progression via the miR-422a.
Yan DG; Liu N; Chao M; Tu YY; Liu WS
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1134-1144. PubMed ID: 30779082
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis.
Sun Z; Guo X; Zang M; Wang P; Xue S; Chen G
J Cell Physiol; 2019 Feb; 234(2):1336-1345. PubMed ID: 30146756
[TBL] [Abstract][Full Text] [Related]
23. LncRNA PFAR facilitates the proliferation and migration of papillary thyroid carcinoma by competitively binding to miR-15a.
Fang T; Yu K
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3037-3048. PubMed ID: 37874339
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-200c-3p Negatively Regulates ATP2A2 and Promotes the Progression of Papillary Thyroid Carcinoma.
Feng YL; Ke T; Wang GL; Qi HY; Xiao Y
Biochem Genet; 2022 Oct; 60(5):1676-1694. PubMed ID: 35079913
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
[TBL] [Abstract][Full Text] [Related]
27. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
[TBL] [Abstract][Full Text] [Related]
29. lncRNA SNHG3 promotes breast cancer progression by acting as a miR‑326 sponge.
Zhang H; Wei N; Zhang W; Shen L; Ding R; Li Q; Li S; Du Y
Oncol Rep; 2020 Oct; 44(4):1502-1510. PubMed ID: 32945476
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
[TBL] [Abstract][Full Text] [Related]
31. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.
Huang Y; Zhang K; Li Y; Dai Y; Zhao H
Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895
[TBL] [Abstract][Full Text] [Related]
32. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
33. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.
Li G; Kong Q
Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NORAD promotes thyroid carcinoma progression by targeting miR-451.
Shi L; Cong YZ; Wang ZJ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6187-6195. PubMed ID: 34730199
[TBL] [Abstract][Full Text] [Related]
35. LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p/WNT5A axis.
Zhou Q; Feng J; Yin S; Ma S; Wang J; Yi H
Biochem Biophys Res Commun; 2021 Mar; 546():83-89. PubMed ID: 33578293
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
38. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
[TBL] [Abstract][Full Text] [Related]
39. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Liu D; Zhang M; Song Y; Yang N
Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
Ma J; Kan Z
Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]